Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mechoulam

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Experientia|May 15, 1975
Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinolN D McCallum, B Yagen, S Levy, et al.
Journal of Chromatography. A|April 1, 1994
Structural features affecting chiral discrimination of terpene derivatives on a carbamated amylose stationary phaseS Abu-Lafi, M Sterin, S Levin, et al.
Nature|January 3, 1970
Metabolism of delta 1(6)-tetrahydro--cannabinol, an active marihuana constituentS H Burstein, F Menezes, E Williamson, et al.
Science (New York, N.Y.)|November 26, 1971
6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activityZ Ben-Zvi, R Mechoulam, H Edery, et al.
Journal of Pharmaceutical Sciences|July 1, 1981
Antiparasitic structure-activity relationships of congocidine derivativesM Bialer, J El-On, B Yagen, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Effect of stereospecific cannabinoids on the immune systemA M Zimmerman, N Titishov, R Mechoulam, et al.
NIDA Research Monograph|January 1, 1996
Cannabinoids: receptors, endogenous ligands and a newly synthesized antagonistF Barth, R Mechoulam, E Fride, et al.
Journal of Medicinal Chemistry|February 28, 1997
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptorT Sheskin, L Hanus, J Slager, et al.
European Journal of Pharmacology|October 4, 1989
Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoidJ J Feigenbaum, S A Richmond, Y Weissman, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1991
Nonpsychotropic synthetic cannabinoids as therapeutic agentsR Mechoulam, A Breuer, J J Feigenbaum, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Experientia|May 15, 1975
Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinolN D McCallum, B Yagen, S Levy, et al.
Journal of Chromatography. A|April 1, 1994
Structural features affecting chiral discrimination of terpene derivatives on a carbamated amylose stationary phaseS Abu-Lafi, M Sterin, S Levin, et al.
Nature|January 3, 1970
Metabolism of delta 1(6)-tetrahydro--cannabinol, an active marihuana constituentS H Burstein, F Menezes, E Williamson, et al.
Science (New York, N.Y.)|November 26, 1971
6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activityZ Ben-Zvi, R Mechoulam, H Edery, et al.
Journal of Pharmaceutical Sciences|July 1, 1981
Antiparasitic structure-activity relationships of congocidine derivativesM Bialer, J El-On, B Yagen, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Effect of stereospecific cannabinoids on the immune systemA M Zimmerman, N Titishov, R Mechoulam, et al.
NIDA Research Monograph|January 1, 1996
Cannabinoids: receptors, endogenous ligands and a newly synthesized antagonistF Barth, R Mechoulam, E Fride, et al.
Journal of Medicinal Chemistry|February 28, 1997
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptorT Sheskin, L Hanus, J Slager, et al.
European Journal of Pharmacology|October 4, 1989
Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoidJ J Feigenbaum, S A Richmond, Y Weissman, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1991
Nonpsychotropic synthetic cannabinoids as therapeutic agentsR Mechoulam, A Breuer, J J Feigenbaum, et al.
Pageof 19